跳至主要内容
临床试验/NCT07225192
NCT07225192尚未招募不适用

Therapy and Tech Study

University of California, Irvine0 个研究点目标入组 204 人开始时间: 2025年11月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
204
主要终点
Patient Health Questionnaire (PHQ-9)

研究概览

简要总结

The investigators want to test if gen AI can support therapy by recruiting patients already in therapy.

详细描述

Recent advancements in AI have led to chatbots, such as ChatGPT, capable of providing therapeutic responses. Early research evaluating chatbots' ability to provide relationship advice and single-session relationship interventions has showed that both laypeople and relationship therapists rate them high on attributes such as empathy and helpfulness. The investigators want to test if chatbots can be a good adjunct to traditional therapy. The investigators hypothesize that participants who regularly use a chatbot as an adjunct to traditional therapy will have better mental health outcomes. Participants will complete baseline, 4-week (post-intervention) and 4-week post-intervention measures and will be invited to gain their therapists ratings.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Double (Participant, Care Provider)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • US Resident
  • English-speaking
  • Self-report having been treated for or diagnosed with generalized anxiety disorder or major depressive disorder by a licensed provider (e.g., MD, DO, LPCC, LCSW, LMFT) in the past 12 months
  • Self-report currently being in individual therapy

排除标准

  • Ever diagnosed with schizophrenia, schizoaffective disorder, bipolar disorder, or hospitalized for suicidality

结局指标

主要结局

Patient Health Questionnaire (PHQ-9)

时间窗: Baseline, 4-week follow-up, 8-week follow-up

Questions about symptoms of depression. Scale is 0-27. Higher score is a worse outcome.

Generalized Anxiety Disorder (GAD-7)

时间窗: Baseline, 4-week follow-up, 8-week follow-up

Questions about symptoms of generalized anxiety disorder. Scale is 0-21. Higher scores is a worse outcome.

Generalized Anxiety Disorder (GAD-7)

时间窗: Baseline, 4-week follow-up, 8-week follow-up

Questions about symptoms of generalized anxiety disorder. Scale is 0-21. Higher scores is a worse outcome.

Patient Health Questionnaire (PHQ-9)

时间窗: Baseline, 4-week follow-up, 8-week follow-up

Questions about symptoms of depression. Scale is 0-27. Higher score is a worse outcome.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Sean D Young

Professor of Emergency Medicine and Informatics

University of California, Irvine

相似试验